EMD-62630

Single-particle
2.66 Å
EMD-62630
3D View Gallery
Deposition: 07/12/2024
Map released: 10/12/2025
Last modified: 10/12/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-62630

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9kxw summary report (pdf.gz) Map-9kxw FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Structure of human B0AT1-ACE2

EMD-62630

Single-particle
2.66 Å
EMD-62630
3D View Gallery
Deposition: 07/12/2024
Map released: 10/12/2025
Last modified: 10/12/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Binary complex of B0AT1and ACE2
Fitted models: 9kxw

Deposition Authors: Imazu T, Miyaguchi I, Hiraizumi M

Structure-guided development of a potent human B0AT1 inhibitor effective in a mouse model of phenylketonuria
Imazu T, Akashi T, Hiraizumi M, Inui Y, Sasaki W, Takahashi T, Todoroki H, Kumanomidou T, Hisano H, Asada H, Kusakizako T, Nishizawa T, Iwata S, Nureki O, Miyaguchi I
To Be Published
Grant Support: